Clinical potential of midostaurin in advanced systemic mastocytosis

Advanced (Ad) systemic mastocytoses (SM) include aggressive SM (ASM) and mast cell leukemia (MCL) with or without an associated clonal hematological non-mast cell lineage disease (AHNMD). They are rare (<15%) but are associated with a poor prognosis due to rapid organ dysfunction. To date, respon...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Lymphat Cancer
Päätekijät: Chandesris, Marie Olivia, Damaj, Gandhi, Lortholary, Olivier, Hermine, Olivier
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2017
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6467340/
https://ncbi.nlm.nih.gov/pubmed/31360083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S87186
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia